William B. Slayton

Improved Early Event-Free Survival With Imatinib in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Children's Oncology Group Study

Kirk R. Schultz, W. Paul Bowman, Alexander Aledo et al. · Journal of Clinical Oncology · 2009 · 700 citations · Full text

Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group Study AALL0031

Kirk R. Schultz, Andrew J. Carroll, Nyla A. Heerema et al. · Leukemia · 2014 · 442 citations · Full text

Hematological Malignancy, Pediatric Hematology, Medicine +6

Dasatinib Plus Intensive Chemotherapy in Children, Adolescents, and Young Adults With Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: Results of Children’s Oncology Group Trial AALL0622

William B. Slayton, Kirk R. Schultz, John A. Kairalla et al. · Journal of Clinical Oncology · 2018 · 242 citations · Full text

Young Adults, Continuous Imatinib, Myeloid Neoplasia +16

High incidence of epithelial cancers in mice deficient for DNA polymerase δ proofreading

Robert E. Goldsby, Laura E. Hays, Xin Chen et al. · Proceedings of the National Academy of Sciences · 2002 · 171 citations · Full text

Use of Alternative Therapies for Children With Cancer

Tracey Friedman, William B. Slayton, Linda S. Allen et al. · PEDIATRICS · 1997 · 153 citations